← FDA DRUG APPROVALS
FDA ANDA · ANDA202053
DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC
Sponsor: REGCON HOLDINGS
APPLICATION
ANDA202053
TYPE
ANDA
ORIGINAL APPROVAL
2014-09-11
LATEST ACTION
2024-02-20
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription
Products
DORZOLAMIDE HYDROCHLORIDEPrescription
DORZOLAMIDE HYDROCHLORIDE EQ 2% BASE · SOLUTION/DROPS · OPHTHALMIC
Approval history
2024-02-20Labeling · Supplement 5 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.